Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Kura Oncology Inc shares valued at $57,916 were sold by Bair Teresa Brophy on May 20 ’24. At $22.15 per share, Bair Teresa Brophy sold 2,615 shares. The insider’s holdings dropped to 68,979 shares worth approximately $1.17 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, DOYLE THOMAS JAMES sold 2,318 shares, netting a total of over 41,262 in proceeds. Following the sale of shares at $17.80 each, the insider now holds 48,093 shares.
Before that, Bair Teresa Brophy had sold 2,053 shares from its account. In a trade valued at $36,544, the Chief Legal Officer traded Kura Oncology Inc shares for $17.80 each. Upon closing the transaction, the insider’s holdings decreased to 2,053 shares, worth approximately $1.17 million.
As published in a research note from Stifel on October 14, 2024, Kura Oncology Inc [KURA] has been rated down from a Buy to a Hold and the price target has been revised to $19 from $26. Analysts at Mizuho started covering the stock with ‘”a Buy”‘ outlook in a report released in late December. As of August 11, 2023, BofA Securities has initiated its “Buy” rating for KURA. Earlier on July 27, 2023, Scotiabank initiated its rating. Their recommendation was “a Sector perform” for KURA stock.
Analyzing KURA Stock Performance
During the last five days, there has been a drop of approximately -6.84%. Over the course of the year, Kura Oncology Inc shares have jumped approximately 18.36%. Nevertheless, trading volume fell to 1.0 million shares from 0.56 million shares the previous day.
Support And Resistance Levels for Kura Oncology Inc (KURA)
RSI (Relative Strength Index) is 28.13 on the 14-day chart, showing oversold technical sentiment.
